Search

pSivida signs $203m research deal with Pfizer

Perth-based biotechnology company pSivida Ltd has signed a collaborative research and license agreement with pharmaceutical giant Pfizer Inc worth $203 million for its drug delivery technologies.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNiQ Disclaimer